285 related articles for article (PubMed ID: 14613852)
1. Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): molecular mechanisms and restoration of intracellular protein processing.
Thomas D; Kiehn J; Katus HA; Karle CA
Cardiovasc Res; 2003 Nov; 60(2):235-41. PubMed ID: 14613852
[TBL] [Abstract][Full Text] [Related]
2. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
Zhou Z; Gong Q; January CT
J Biol Chem; 1999 Oct; 274(44):31123-6. PubMed ID: 10531299
[TBL] [Abstract][Full Text] [Related]
3. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel.
Furutani M; Trudeau MC; Hagiwara N; Seki A; Gong Q; Zhou Z; Imamura S; Nagashima H; Kasanuki H; Takao A; Momma K; January CT; Robertson GA; Matsuoka R
Circulation; 1999 May; 99(17):2290-4. PubMed ID: 10226095
[TBL] [Abstract][Full Text] [Related]
5. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene.
Roti EC; Myers CD; Ayers RA; Boatman DE; Delfosse SA; Chan EK; Ackerman MJ; January CT; Robertson GA
J Biol Chem; 2002 Dec; 277(49):47779-85. PubMed ID: 12270925
[TBL] [Abstract][Full Text] [Related]
6. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.
January CT; Gong Q; Zhou Z
J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1413-8. PubMed ID: 11196567
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.
Paulussen A; Raes A; Matthijs G; Snyders DJ; Cohen N; Aerssens J
J Biol Chem; 2002 Dec; 277(50):48610-6. PubMed ID: 12354768
[TBL] [Abstract][Full Text] [Related]
8. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.
Delisle BP; Anderson CL; Balijepalli RC; Anson BD; Kamp TJ; January CT
J Biol Chem; 2003 Sep; 278(37):35749-54. PubMed ID: 12837749
[TBL] [Abstract][Full Text] [Related]
9. Identification of a COOH-terminal segment involved in maturation and stability of human ether-a-go-go-related gene potassium channels.
Akhavan A; Atanasiu R; Shrier A
J Biol Chem; 2003 Oct; 278(41):40105-12. PubMed ID: 12885765
[TBL] [Abstract][Full Text] [Related]
10. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome.
Ficker E; Dennis AT; Obejero-Paz CA; Castaldo P; Taglialatela M; Brown AM
J Mol Cell Cardiol; 2000 Dec; 32(12):2327-37. PubMed ID: 11113008
[TBL] [Abstract][Full Text] [Related]
11. Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death.
Clancy CE; Rudy Y
Cardiovasc Res; 2001 May; 50(2):301-13. PubMed ID: 11334834
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel.
Moss AJ; Zareba W; Kaufman ES; Gartman E; Peterson DR; Benhorin J; Towbin JA; Keating MT; Priori SG; Schwartz PJ; Vincent GM; Robinson JL; Andrews ML; Feng C; Hall WJ; Medina A; Zhang L; Wang Z
Circulation; 2002 Feb; 105(7):794-9. PubMed ID: 11854117
[TBL] [Abstract][Full Text] [Related]
13. Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.
Ficker E; Thomas D; Viswanathan PC; Dennis AT; Priori SG; Napolitano C; Memmi M; Wible BA; Kaufman ES; Iyengar S; Schwartz PJ; Rudy Y; Brown AM
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1748-56. PubMed ID: 11009462
[TBL] [Abstract][Full Text] [Related]
14. Defective human Ether-à-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus.
Kupershmidt S; Yang T; Chanthaphaychith S; Wang Z; Towbin JA; Roden DM
J Biol Chem; 2002 Jul; 277(30):27442-8. PubMed ID: 12021266
[TBL] [Abstract][Full Text] [Related]
15. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects.
Zhou Z; Gong Q; Epstein ML; January CT
J Biol Chem; 1998 Aug; 273(33):21061-6. PubMed ID: 9694858
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
Isbrandt D; Friederich P; Solth A; Haverkamp W; Ebneth A; Borggrefe M; Funke H; Sauter K; Breithardt G; Pongs O; Schulze-Bahr E
J Mol Med (Berl); 2002 Aug; 80(8):524-32. PubMed ID: 12185453
[TBL] [Abstract][Full Text] [Related]
17. Is restoration of intracellular trafficking clinically feasible in the long QT syndrome?: The example of HERG mutations.
Kaufman ES; Ficker E
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):320-2. PubMed ID: 12716119
[No Abstract] [Full Text] [Related]
18. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
19. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG.
Ficker E; Dennis AT; Wang L; Brown AM
Circ Res; 2003 Jun; 92(12):e87-100. PubMed ID: 12775586
[TBL] [Abstract][Full Text] [Related]
20. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
